Katarina Öhrling

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Staffan Welin, Seppo W. Langer, Lene Weber Vestermark et al. · Annals of Oncology · 2012 · 1K citations

Prognostic Factors, Glioma, Gastrointestinal Oncology +10

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma

Robert H.I. Andtbacka, Frances A. Collichio, Kevin J. Harrington et al. · Journal for ImmunoTherapy of Cancer · 2019 · 413 citations · Full text

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

Aurélien Marabelle, Robert Hans Ingemar Andtbacka, Kevin J. Harrington et al. · Annals of Oncology · 2018 · 204 citations · Full text

The number of analyzed lymph nodes – a prognostic factor in colorectal cancer

David Edler, Katarina Öhrling, Marja Hallström et al. · Acta Oncologica · 2007 · 80 citations · Full text

Analyzed Lymph Nodes, Surgical Oncology, Gastrointestinal Oncology +11

HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome

Frida Lédel, Marja Hallström, Peter Ragnhammar et al. · European Journal of Cancer · 2013 · 51 citations

Medicine, Primary Colorectal Cancer, Colorectal Cancer +9